Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers

Conclusions: These prevalence estimates are important for understanding age-related trends in amyloid positivity and AD signature cortical thickness in the population, and for potentially projecting the future burden of biomarkers in elderly persons.

http://www.neurology.org/cgi/content/short/89/20/2039?rss=1

Source: Neurology - November 13, 2017 Category: Neurology Authors: Roberts, R. O., Knopman, D. S., Syrjanen, J. A., Aakre, J. A., Vassilaki, M., Kremers, W. K., Mielke, M. M., Machulda, M. M., Graff-Radford, J., Geda, Y. E., Vemuri, P., Lowe, V., Jack, C. R., Petersen, R. C. Tags: MRI, PET, Alzheimer's disease, MCI (mild cognitive impairment), Prevalence studies ARTICLE Source Type: research